PKD2 and kidney disorder: Despite these limitations, our data suggest that a small, well‐designed panel remains a cost‐effective screening tool for common forms of genetic kidney disease, particularly in resource‐limited contexts or when clinical suspicion strongly indicates one of the most prevalent genes (e.g., PKD1, PKD2, or COL4A).